Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3 Multi-Center Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5 % Minoxidil Foam vs. 2 % Minoxidil Solution in Females for the Treatment of Female Pattern Hair Loss - Androgenetic Alopecia (MINALO3004, NCT01145625)

NCT01145625 is registered in ClinicalTrials.gov with Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc. as lead sponsor.

NCT NCT01145625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01145625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3 Multi-Center Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5 % Minoxidil Foam vs. 2 % Minoxidil Solution in Females for the Treatment of Female Pattern Hair Loss - Androgenetic Alopecia (MINALO3004, NCT01145625)
Lead sponsor
Johnson & Johnson Healthcare Products Division of McNEIL-PPC, Inc.
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2010
Completion date
February 29, 2012
Enrollment
322 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia